MedTrace Logo

Usefulness of Capillary Refill Time and Skin Mottling Score to Predict Intensive Care Unit Admission

NCT03831022 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2019-02-06

No results posted yet for this study

Summary

In the emergency department (ED), the severity assessment of shock is a fundamental step prior to the admission in intensive care unit (ICU). As biomarkers are time consuming to evaluate severity of the micro and macro-circulation alteration, capillary refill time and skin mottling score are 2 simples, available clinical criteria validated to predict mortality in the ICU.

The aim of this study is to provide clinical evidence that capillary refill time and skin mottling score assessed in the ED also predict ICU admission of patients with septic or haemorrhagic shock.

Conditions

  • Shock, Septic
  • Shock, Hemorrhagic

Interventions

OTHER

Capillary refill time and skin mottling score measurement at the admission to the emergency department

Patients who meet the inclusion criteria and none of the non-inclusion criteria will benefit from capillary refill time and skin mottling score measurement at the admission to the emergency department (ED) and followed during their hospital stay to precise the destination after ED (home, ICU, ward) and 30- and 90-days mortality after hospital admission.

Sponsors & Collaborators

  • Hôpital Cochin

    collaborator OTHER

  • University Grenoble Alps

    collaborator OTHER

  • University Hospital, Strasbourg, France

    collaborator OTHER

  • Poitiers University Hospital

    collaborator OTHER

  • Begin Military Hospital

    collaborator UNKNOWN

  • Argenteuil Hospital

    collaborator UNKNOWN

  • University Hospital, Limoges

    collaborator OTHER

  • University Hospital, Marseille

    collaborator OTHER

  • Hôpital Necker-Enfants Malades

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-17
Primary Completion
2020-12-17
Completion
2020-12-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03831022 on ClinicalTrials.gov